US 12065498
Methods of making bispecific anti-CD307E and anti-BCMA chimeric antigen receptors and uses of the same
granted A61KA61K2039/5156A61K2039/5158
Quick answer
US patent 12065498 (Methods of making bispecific anti-CD307E and anti-BCMA chimeric antigen receptors and uses of the same) held by Cell Design Labs, Inc. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cell Design Labs, Inc.
- Grant date
- Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/5156, A61K2039/5158, A61K2239/29, A61K2239/48